MedPath
FDA Approval

ZELAPAR

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Bausch Health US, LLC
DUNS: 831922468
Effective Date
June 1, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Selegiline(1.25 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Catalent Pharma Solutions Limited

Bausch Health US, LLC

237676320

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ZELAPAR

Product Details

NDC Product Code
0187-0453
Application Number
NDA021479
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
June 1, 2021
Code: 6W731X367QClass: ACTIBQuantity: 1.25 mg in 1 1
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
ASPARTAMEInactive
Code: Z0H242BBR1Class: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327LClass: IACT
© Copyright 2025. All Rights Reserved by MedPath